Prostate cancer: FDA reporting patterns
80,151 FDA FAERS reports mention Prostate cancer. 79,894 reports have a serious outcome flag.
Medicines named as suspect
- Ranitidine: 60,644 reports
- Leuprolide: 2,132 reports
- Etanercept: 833 reports
- Adalimumab: 821 reports
- Abiraterone: 728 reports
- Enzalutamide: 697 reports
- Infliximab: 676 reports
- Valsartan: 548 reports
- Methotrexate: 508 reports
- Lenalidomide: 474 reports
- Rituximab: 401 reports
- Sildenafil: 388 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.